Literature DB >> 25440053

Inflammation versus host defense in obesity.

Huaizhu Wu1, Christie M Ballantyne2.   

Abstract

Obesity is characterized by a state of low-grade, chronic inflammation. Wang et al. (2014) report that immune cells from obese mice have decreased production of IL-22, a cytokine involved in immune responses and inflammation, and reveal therapeutic effects of exogenous IL-22 against obesity-linked metabolic dysfunctions.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25440053      PMCID： PMC4755485          DOI： 10.1016/j.cmet.2014.10.013

Source DB:  PubMed          Journal:  Cell Metab        ISSN： 1550-4131            Impact factor:   27.287


  10 in total

Review 1.  Interleukin-6 and diabetes: the good, the bad, or the indifferent?

Authors:  Ole P Kristiansen; Thomas Mandrup-Poulsen
Journal:  Diabetes       Date:  2005-12       Impact factor: 9.461

2.  Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes.

Authors:  Xiaoting Wang; Naruhisa Ota; Paolo Manzanillo; Lance Kates; Jose Zavala-Solorio; Celine Eidenschenk; Juan Zhang; Justin Lesch; Wyne P Lee; Jed Ross; Lauri Diehl; Nicholas van Bruggen; Ganesh Kolumam; Wenjun Ouyang
Journal:  Nature       Date:  2014-08-06       Impact factor: 49.962

Review 3.  Functional interactions between the gut microbiota and host metabolism.

Authors:  Valentina Tremaroli; Fredrik Bäckhed
Journal:  Nature       Date:  2012-09-13       Impact factor: 49.962

4.  T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity.

Authors:  Huaizhu Wu; Sudip Ghosh; Xiaoyuan Dai Perrard; Lili Feng; Gabriela E Garcia; Jerry L Perrard; John F Sweeney; Leif E Peterson; Lawrence Chan; C Wayne Smith; Christie M Ballantyne
Journal:  Circulation       Date:  2007-02-12       Impact factor: 29.690

5.  T cell-derived IL-22 amplifies IL-1β-driven inflammation in human adipose tissue: relevance to obesity and type 2 diabetes.

Authors:  Elise Dalmas; Nicolas Venteclef; Charles Caer; Christine Poitou; Isabelle Cremer; Judith Aron-Wisnewsky; Sébastien Lacroix-Desmazes; Jagadeesh Bayry; Srinivas V Kaveri; Karine Clément; Sébastien André; Michèle Guerre-Millo
Journal:  Diabetes       Date:  2014-02-11       Impact factor: 9.461

6.  Lymphotoxin regulates commensal responses to enable diet-induced obesity.

Authors:  Vaibhav Upadhyay; Valeriy Poroyko; Tae-jin Kim; Suzanne Devkota; Sherry Fu; Donald Liu; Alexei V Tumanov; Ekaterina P Koroleva; Liufu Deng; Cathryn Nagler; Eugene B Chang; Hong Tang; Yang-Xin Fu
Journal:  Nat Immunol       Date:  2012-08-26       Impact factor: 25.606

7.  Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages.

Authors:  Mario Kratz; Brittney R Coats; Katherine B Hisert; Derek Hagman; Vesco Mutskov; Eduard Peris; Kelly Q Schoenfelt; Jessica N Kuzma; Ilona Larson; Peter S Billing; Robert W Landerholm; Matthew Crouthamel; David Gozal; Seungmin Hwang; Pradeep K Singh; Lev Becker
Journal:  Cell Metab       Date:  2014-09-18       Impact factor: 27.287

Review 8.  Inflammation and lipid signaling in the etiology of insulin resistance.

Authors:  Christopher K Glass; Jerrold M Olefsky
Journal:  Cell Metab       Date:  2012-05-02       Impact factor: 27.287

Review 9.  Therapeutic opportunities of the IL-22-IL-22R1 system.

Authors:  Robert Sabat; Wenjun Ouyang; Kerstin Wolk
Journal:  Nat Rev Drug Discov       Date:  2014-01       Impact factor: 84.694

10.  High fat diet induces formation of spontaneous liposarcoma in mouse adipose tissue with overexpression of interleukin 22.

Authors:  Zheng Wang; Ling Yang; Yuhui Jiang; Zhi-Qiang Ling; Zhigang Li; Yuan Cheng; Heng Huang; Lingdi Wang; Yi Pan; Zhenzhen Wang; Xiaoqiang Yan; Yan Chen
Journal:  PLoS One       Date:  2011-08-29       Impact factor: 3.240
  10 in total
  6 in total

Review 1.  Skeletal muscle inflammation and insulin resistance in obesity.

Authors:  Huaizhu Wu; Christie M Ballantyne
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

2.  Transdermal Delivery of Metformin Using Dissolving Microneedles and Iontophoresis Patches for Browning Subcutaneous Adipose Tissue.

Authors:  Mehrnaz Abbasi; Zhaoyang Fan; John A Dawson; Shu Wang
Journal:  Pharmaceutics       Date:  2022-04-17       Impact factor: 6.525

3.  Deficiency of intestinal mucin-2 protects mice from diet-induced fatty liver disease and obesity.

Authors:  Phillipp Hartmann; Caroline T Seebauer; Magdalena Mazagova; Angela Horvath; Lirui Wang; Cristina Llorente; Nissi M Varki; Katharina Brandl; Samuel B Ho; Bernd Schnabl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-12-23       Impact factor: 4.052

4.  Interleukin-22, a potent target for treatment of non-autoimmune diseases.

Authors:  Yue Zheng; Tong Li
Journal:  Hum Vaccin Immunother       Date:  2018-10-31       Impact factor: 3.452

5.  Adipose tissue glycogen accumulation is associated with obesity-linked inflammation in humans.

Authors:  Victòria Ceperuelo-Mallafré; Miriam Ejarque; Carolina Serena; Xavier Duran; Marta Montori-Grau; Miguel Angel Rodríguez; Oscar Yanes; Catalina Núñez-Roa; Kelly Roche; Prasanth Puthanveetil; Lourdes Garrido-Sánchez; Enrique Saez; Francisco J Tinahones; Pablo M Garcia-Roves; Anna Ma Gómez-Foix; Alan R Saltiel; Joan Vendrell; Sonia Fernández-Veledo
Journal:  Mol Metab       Date:  2015-10-16       Impact factor: 7.422

Review 6.  Therapeutic Opportunities of IL-22 in Non-Alcoholic Fatty Liver Disease: From Molecular Mechanisms to Clinical Applications.

Authors:  Wenjing Zai; Wei Chen; Hongrui Liu; Dianwen Ju
Journal:  Biomedicines       Date:  2021-12-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.